Well, hopefully, it will be short, Mr. Chair.
The legislation that we're speaking about here indicates that products derived from cannabis that are approved by Health Canada and have drug identification numbers and can only be acquired with a prescription will be exempt from the excise duty for product offerings.
What limits does this place on products that are available that require medical marijuana? As well, you mentioned the 0.3% THC. I'm assuming this wouldn't be of much assistance to those suffering from chronic pain or illness. Is that the case?